Position in CLDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,047,000
+$10,187,000 QoQ
Shares Held
700,000
+40.0% QoQ
Ownership
0.891%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#30
of 252 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Jun 30, 2022CallValue
$3,909,200
CallShares
145,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. CLDX ranks #20 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
3,750,000 | $132,712,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
987,000 | $131,004,510 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
1,279,134 | $113,561,516 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
1,595,000 | $96,274,200 | |
| 5 | ERAS |
Erasca, Inc.
|
5,250,000 | $96,180,000 | |
| 6 | INSM |
INSMED Inc
|
650,000 | $69,303,000 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
185,000 | $61,936,150 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
590,000 | $56,150,300 |
All Filings in CLDX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,047,000 | 700,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $15,860,000 | 500,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $9,506,000 | 350,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,761,000 | 300,000 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $252,497 | 9,992 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,248,750 | 125,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $17,594,554 | 475,400 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,404,700 | 510,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,864,000 | 400,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,128,000 | 150,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,952,961 | 87,031 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $1,799,000 | 50,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,902,700 | 110,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,248,800 | 80,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,078,400 | 40,000 | Shares | Sole | 2022-08-12 | |
| 2022-06-30 | $3,909,200 | 145,000 | Call | Sole | 2022-08-12 | |
| 2022-03-31 | $4,257,500 | 125,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,864,000 | 100,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,167,914 | 40,154 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,672,000 | 50,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,678,000 | 130,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,314,000 | 75,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||